Calamos Advisors »

Conmed Corp Note 2.250 6/1 shares owned by Calamos Advisors

Quarter-by-quarter ownership of Conmed Corp Note 2.250 6/1 shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Conmed Corp Note 2.250 6/1

Tip: Access up to 7 years of quarterly data

All positions including Conmed Corp Note 2.250 6/1 held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conmed Corp Note 2.250 6/1 by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $53M 58M 0.92
2023-12-31 $58M 58M 1.00
2023-09-30 $56M 58M 0.95
2023-06-30 $55M 49M 1.12

More positions owned by Calamos Advisors

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Eli Lilly & Co. (LLY)
Pioneer Nat Res Note 0.250% 5/1 (Principal)
Visa Com Cl A (V)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
UnitedHealth (UNH)

View all positions for Calamos Advisors

Top funds holding Conmed Corp Note 2.250 6/1

Wolverine Asset Management
Calamos Advisors
MacKay Shields
Millennium Management
Highbridge Capital Management
Citadel Advisors
Lazard Asset Management
Tenor Capital Management
Shenkman Capital Management
Lombard Odier Asset Management
Zazove Associates
Wells Fargo & Company
Absolute Investment Advisers
Bnp Paribas Arbitrage, Snc
Nuveen Asset Management

View all funds holding Conmed Corp Note 2.250 6/1